Evidence map›Paper›PMID 28462893›Full record

ArticleJournal of diabetes and its complications2017

Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S.

John M Wentworth, Kim M Dalziel, Paul E O'Brien, Paul Burton, Frackson Shaba, Philip M Clarke, Neda Laiteerapong, Wendy A Brown

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes and its complications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Economics and Policy in Bariatric Surgery.Current diabetes reports · 2019
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

John M WentworthCentre for Obesity Research and Education, Monash University, Clayton, Australia; Walter and Eliza Hall Institute, Melbourne University, Parkville, Australia; Royal Melbourne Hospital Department of Medicine, Parkville, Australia. Electronic address: wentworth@wehi.edu.au.
Kim M DalzielSchool of Population and Global Health, University of Melbourne, Parkville, Australia.
Paul E O'BrienCentre for Obesity Research and Education, Monash University, Clayton, Australia.
Paul BurtonCentre for Obesity Research and Education, Monash University, Clayton, Australia.
Frackson ShabaSchool of Population and Global Health, University of Melbourne, Parkville, Australia.
Philip M ClarkeSchool of Population and Global Health, University of Melbourne, Parkville, Australia.
Neda LaiteerapongDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Wendy A BrownCentre for Obesity Research and Education, Monash University, Clayton, Australia.
Monash University · AUUniversity of Melbourne · AUUniversity of Chicago · USWalter and Eliza Hall Institute of Medical Research · AU

Funding

Research Design, Data, and Analytics CoreP30DK092949 · NIDDK · UNIVERSITY OF CHICAGO · PI MARSHALL H CHIN · 2011 to 2026
$10.0M
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision MakingK23DK097283 · NIDDK · UNIVERSITY OF CHICAGO · PI LAITEERAPONG, NEDA · 2012 to 2016
$880k
NIDDK NIH HHS K23 DK097283NIDDK NIH HHS P30 DK092949
6 · The paper itself

Abstract

aimTo determine the cost-effectiveness of gastric band surgery in overweight but not obese people who receive standard diabetes care.

methodA microsimulation model (United Kingdom Prospective Diabetes Study outcomes model) was used to project diabetes outcomes and costs from a two-year Australian randomized trial of gastric band (GB) surgery in overweight but not obese people (BMI 25 to 30kg/m

resultsThe incremental cost-effectiveness ratio for GB surgery at two years exceeded $90,000 per quality-adjusted life year gained but decreased to $52,000, $29,000 and $22,000 when the health benefits of surgery were assumed to endure for 5, 10 and 15 years respectively. The cost-effectiveness of GB surgery was sensitive to utility gained from weight loss and, to a lesser degree, the costs of GB surgery. However, the cost-effectiveness of GB surgery was affected minimally by improvements in HbA1c, systolic blood pressure and cholesterol.

conclusionsGB surgery for overweight but not obese people with T2D appears to be cost-effective in the U.S. setting if weight loss endures for more than five years. Health utility gained from weight loss is a critical input to cost-effectiveness estimates and therefore should be routinely measured in populations undergoing bariatric surgery.

Indexed as

Bariatric SurgeryModels, EconomicAustraliaBody Mass IndexCombined Modality TherapyCost-Benefit AnalysisCost of IllnessCosts and Cost AnalysisDiabetes Mellitus, Type 2Health Care CostsHumansMiddle AgedNutrition SurveysOverweightQuality of LifeRandomized Controlled Trials as TopicBariatric surgeryCost-effectivenessGastric band surgeryOverweight but not obeseType 2 diabetes

Identifiers

PMID28462893
PMCPMC5528847
OpenAlexW2606007764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.